GoHealth (GOCO) Form 3: Director William L. Transier Reports No Holdings

William L. Transier filed an Initial Form 3 reporting his relationship to GoHealth, Inc. (GOCO) as a director.

Rhea-AI Filing Summary

William L. Transier filed an Initial Form 3 reporting his relationship to GoHealth, Inc. (GOCO) as a director. The event date is 08/06/2025. The filing states that no securities are beneficially owned by the reporting person and includes Exhibit 24 (Power of Attorney). The form lists a Chicago address for the reporting person and is signed on behalf of Transier by an attorney-in-fact on 08/08/2025.

Insights

Corporate Governance Expert

TL;DR: Form 3 discloses a directorship with no beneficial ownership reported; routine initial disclosure.

The filing indicates William L. Transier became a director of GoHealth, Inc. and filed an initial Section 16 statement. Critically, the Form 3 expressly states that the reporting person holds no beneficial ownership of the issuer's securities at the time of filing and attaches Exhibit 24 for power of attorney authorization. From a governance perspective, this is a standard disclosure when an individual joins a board and does not yet hold equity; it establishes compliance with Section 16 reporting requirements but contains no transactions or holdings that would affect shareholder interests.

Securities Compliance Analyst

TL;DR: Administrative initial filing complies with reporting rules; no material holdings or derivatives disclosed.

The Form 3 meets basic Section 16(a) obligations by identifying the reporting person, relationship to the issuer, event date (08/06/2025), and explicitly stating "No securities are beneficially owned." The presence of a signed Exhibit 24 indicates delegation of signature authority. There are no entries in Tables I or II for non-derivative or derivative securities, so there are no late-reported trades or outstanding options to review.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Form 3 filed for GOCO disclose?

The Form 3 names William L. Transier as a director of GoHealth, Inc. and states he does not beneficially own any securities of the issuer as of the event date.

What is the event date listed on the GOCO Form 3?

The event date on the filing is 08/06/2025.

Was any equity or derivative ownership reported for the reporting person on this Form 3?

No. The filing explicitly states no securities are beneficially owned and Tables I and II contain no holdings.

Who signed the Form 3 for the reporting person?

The Form 3 was signed by Bradley Burd, Attorney-in-fact on 08/08/2025.

Does the filing include a power of attorney?

Yes. The filing references Exhibit 24 - Power of Attorney.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/08/2025 - 02:39 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

TRANSIER WILLIAM L

(Last) (First) (Middle)

222 W MERCHANDISE MART PLAZA

SUITE 1750

(Street)

CHICAGO IL 60654

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/06/2025

3. Issuer Name and Ticker or Trading Symbol
GoHealth, Inc. [ GOCO ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit 24 - Power of Attorney.

No securities are beneficially owned.

	/s/ Bradley Burd, Attorney-in-fact	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.